Florian Grebien did his PhD jointly supervised by Ernst Müllner of the Medical University Vienna and Hartmut Beug of the Research Institute for Molecular Pathology (IMP) in Vienna. For his post-doctoral research he joined the team of Giulio Superti-Furga at the Research Center for Molecular Medicine (CeMM), Vienna. From 2014 to 2018, he was a Principal Investigator and group leader at the Ludwig Boltzmann Institute for Cancer Research (LBI-CR) in Vienna. In January 2018, he was appointed Professor and head of the institute for Medical Biochemistry at the University of Veterinary Medicine Vienna.
Florian Grebien’s research focuses on acute myeloid leukemia (AML), a cancer of white blood cells that is characterized by the rapid growth of abnormal myeloid cells that accumulate in the bone marrow and interfere with the production of normal blood cells. The Grebien laboratory aims to contribute to a better understanding of the molecular mechanisms of leukemia development. We study cellular and molecular effects of leukemia-associated oncoproteins through the development and use of novel tools, including cell culture and mouse models, Next Generation Sequencing, Mass Spectrometry and primary patient samples.

Manuela Thullner
Secretary

Bernhard Alber
MSc student
“I am characterizing the role of RNA metabolism in AML, applying technologies such as CRISPR/Cas9-based screening.”

Melanie Allram
PhD student
“I am investigating NUP98-fusion proteins and their interaction partners in the context of biomolecular condensates as drivers for leukemogenic gene expression.”


Thomas Eder
PostDoc
“As bioinformatician I have a special interest in cutting edge NGS technologies, the resulting data and its applications as well as tool development. My research focuses on normalization methods and techniques used for differential gene expression and differential ChIP-seq.”



Gabriele Manhart
Technician (and artist)
“Eager to acquire experience in state of the art techniques and gain a profound background in cancer research, specifically acute myeloid leukaemia, I am participating in various projects and help wherever needed.”


Martin Piontek
PhD student
“My research focuses on molecular factors that mediate the response to recently estabilished targeted therapies in acute myeloid leukemia.”


Patricia Testori
MSc student
“My goal is to elucidate the role of GATA2 in AML by generating relevant models. “


Alumni
- Jisha Puthenpurayil (2022)
- Martin Piontek, Master student (2020-2021)
- Edwin Rzepa, BSc Student (2021)
- Torben Redmer, PostDoc (2019-2021)
- Johannes Schmoellerl, PhD student (2014-2020)
- Theresa Humer, Master student (2019-2020)
- Luisa Schmidt, PhD student (2014-2019)
- Stefan Terlecki-Zaniewicz, PhD student (2016-2019)
- Fabio Liberante, PostDoc (2016-2019)
- Lisa Scheiblecker, Master student (2017-2018)
- Konstantina Chatziathanasiou, Technician (2017-2018)
- Nathalie Kuchynka, Bachelor student (2018)
- Anna Skucha, PhD student (2012-2018)
- Anna Katschnig, Technician (2017-2018)
- Frank Ruge, Master Student (2017)
- Christa Van der Veen, Master student (2016)
- Stephanie Kreimel, Bachelor student (2015)
Visiting researchers / Interns
- Ezgi Aslan
- Helene Breid
- Anna Falkner
- Guillermo Fernandez
- Daniel Freund
- Erna Islamagić
- Marketa Kovalova
- Theresa Muthspiel
- Claudio Schmidt
- Maximilian Sexl
- Rathick Sivalingam
- Samantha Tauchmann
- Sinem Usluer
- Giacomo Volpe
- Tamina Weiss
